Zydus Lifesciences Limited (including its subsidiaries/affiliates, hereafter referred to as “Zydus”) an innovation-led life-sciences company with an international presence, announces the successful closure of the Asset Purchase Agreement, Share Purchase Agreement, and the exclusive Licensing Agreement with Agenus Inc. (NASDAQ: AGEN). The transaction establishes Zydus’ advanced manufacturing facilities in the global biologics contract development and manufacturing organization (“CDMO”) business. All acquired manufacturing assets and operations will be housed under a newly formed, dedicated U.S. based subsidiary named Zylidac Bio LLC.
Read the full article: Zydus Lifesciences Limited Completes the Acquisition of Agenus Inc.’s Biologics Manufacturing Facilities, Launches Zylidac Bio LLC in the U.S. //
Source: https://www.prnewswire.com/news-releases/zydus-lifesciences-limited-completes-the-acquisition-of-agenus-incs-biologics-manufacturing-facilities-launches-zylidac-bio-llc-in-the-us-302662438.html